Thrombin-induced alterations in endothelial permeability.
Figure 15 summarizes the current understanding of mechanisms of endothelial permeability alterations induced with thrombin. If thrombin generation exceeds the antiprotease activity, thrombin results in clotting of fibrinogen and intravascular fibrin accumulation. Pulmonary neutrophil sequestration also occurs after fibrin deposition, and this is related to the degree and duration of fibrin sequestration. Neutrophil activation appears to be an essential requirement for the mediation of the pulmonary vascular injury. Thrombin-induced intravascular coagulation results in the generation of lipid mediators (LTB4 and HETEs), which may be involved in increasing endothelial permeability. The release of thrombin in higher concentrations during lysis of fibrin (sequence; see text) FIGURE 15. Hypothesis showing mechanisms of thrombin-induced increase in endothelial permeability to proteins. Thrombin may have direct effects on endothelial permeability, or thrombin induced fibrinogen clotting, activation of neutrophils, and the release of lipid metabolites that subsequently lead to an increase in endothelial permeability. clots may induce a direct formation of interendothelial "gaps." Therefore, the vascular injury induced by neutrophil activation and the formation of endothelial "gaps" induced directly by thrombin can both increase the endothelial permeability to proteins. Thrombin is an important mediator of increased endothelial permeability to macromolecules, and may participate in the inflammatory response. In this regard, thrombin may be similar to other mediators (such as histamine and serotonin) that have been previously documented to increase macromolecule transport across the endothelium. The implications of free thrombin in increasing endothelial permeability may be greater because thrombin not only has a direct effect on endothelial permeability, but also induces clotting of fibrinogen and the subsequent generation of mediators that activate neutrophils and that in turn can induce endothelial injury.
D008841:Actin Cytoskeleton / Q000648:ultrastructure; D000418:Albumins / Q000378:metabolism; D000818:Animals; D001777:Blood Coagulation; D002199:Capillary Permeability / Q000187:drug effects*; D002417:Cattle; D004727:Endothelium / Q000648:ultrastructure; D066298:In Vitro Techniques; D007958:Leukocyte Count; D007975:Leukotriene B4 / Q000378:metabolism; D008196:Lymph / Q000502:physiology; D009504:Neutrophils / Q000502:physiology; D010976:Platelet Count; D011453:Prostaglandins / Q000378:metabolism; D011652:Pulmonary Circulation; D012756:Sheep; D013917:Thrombin / Q000494:pharmacology*; D013997:Time Factors
D000418:Albumins; D011453:Prostaglandins; D007975:Leukotriene B4; D013917:Thrombin